May 16, 2018

Meet Miguel Regueiro, MD, Cleveland Clinic’s New Chairman of Gastroenterology and Hepatology

Innovator advocates patient-centered medical homes for GI specialties

18-DDI-339-Regueiro-CQD

Pennsylvania native Miguel Regueiro, MD, isn’t just a gastroenterologist ― he’s a natural builder. At the University of Pittsburgh Medical Center (UPMC), he built its Inflammatory Bowel Disease (IBD) program from 50 patients and one physician (himself) into a comprehensive clinical and research program with seven IBD specialists, plus clinical nurses, research nurse coordinators, colorectal surgeons and a multispecialty team of support personnel, who cared for more than 11,000 patients.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Moreover, he had flipped convention on its ear by restructuring the program as a patient-centered medical home for IBD.

But after a conversation with Digestive Disease & Surgery Institute Chairman Conor Delaney, MD, PhD, he saw opportunities to build on the concept here.

“Dr. Delaney’s vision, and that of Cleveland Clinic overall, was aligned with my interests,” says Dr. Regueiro. “Their desire to build a team to develop clinical programs that feed research and education resonated with me.”

He was struck by learning that the concept of a patient-centered medical home has been in Cleveland Clinic’s culture since its inception. “They were interested in having me reimagine the program for IBD patients and expanding this alternative model of care to other specialties within the Digestive Disease & Surgery Institute,” he says.

An outside-the-box concept

Dr. Regueiro’s interest in creating a medical home for patients with IBD came from conversations with his own patients. “The most important person in our relationship is the patient. It’s about what they want from the care experience, not about what we want. Turns out that what we were doing as healthcare providers was not patient-centric, and we had a lot to learn from the most important ‘stakeholders’ — our patients and their families.” he says.

The core of the problem, he says, is that the management of IBD has traditionally been segmented, lacks continuity and does not sufficiently address chronic pain and psychosocial symptoms.

To prevent “siloed” care, he felt a new model was needed, a model that would manage patients with an integrated team of providers levered through a payer-provider partnership. That led him to create a multispecialty team that would provide one-stop shopping for IBD patients. In a single clinic visit, patients see a gastroenterologist, nurse, dietitian, social worker and psychiatrist, have their status entered in a database and get a surgical consult, if necessary.

Advertisement

“The idea is to provide comprehensive care in an efficient manner, with minimal disruption to a patient’s life and personal schedule,” he says.

Between visits, ongoing care is offered through remote monitoring and telemedicine connections. For patients with the most need, nurses and social workers provide home visits.

Building on success

At Cleveland Clinic, Dr. Regueiro plans to continue building programs that deliver whole-person, patient-centered care for chronic diseases using a multispecialty, population-health approach, starting with IBD. “My interests and research lie in how medicine and surgery interface in Crohn’s, and specifically the post-operative Crohn’s disease model,” he says.

He will also apply lessons learned to liver, obesity, metabolic and functional bowel diseases and other specialties of GI and hepatology. “I hope to ensure the members of all departments within the DDSI are integrated into a cohesive, well-function team,” he says.

In the process, patient flow will be restructured so that routine patients are treated in select regional hospitals, and the most complex cases are handled on Cleveland Clinic’s main campus.

Furthering research

To support existing research in GI and hepatology, Dr. Regueiro plans to expand clinical research and formalize a clinical trials team. He would like to see each service line have a prospective registry, and he will encourage big data analysis and outcomes research that links to translational science and personalized medicine.

“I would also like to develop research in healthcare economics and design population health and epidemiology studies,” he says. “As our healthcare delivery evolves new models of care that are reliant on integration of providers, payers, industry, innovative technology and patients, we will have an opportunity to write a new ‘healthcare playbook.’ To do this, understanding the economic impact of these models, and how regional and national patient populations are cared for, are at the core of next-generation medicine.”

Advertisement

Innovation in education

His plans for growing the department’s already excellent education programs include integrating his Inflammatory Bowel Disease Live Interinstitutional and Interdisciplinary Videoconference Education (“IBD Live”) series with Cleveland Clinic. This virtual weekly IBD meeting currently attracts 200 physicians from throughout the U.S.

He plans to work with department educators to develop other innovative educational programs that span the entire physician and healthcare educational experience, from medical students to residents, fellows and practicing clinicians.

Finally, recognizing that on May 14 he stepped into a department staffed with world-class physicians, staff, researchers and educators, Dr. Regueiro pledges to provide them with the necessary support to continue on their path of excellence.

“I will work with each member of the Department of Gastroenterology and Hepatology to ensure there is an opportunity to achieve career goals and advance the mission of the institute, without sacrificing quality of life,” he says.

Related Articles

surgeon-scientist
October 16, 2023
Surgeon-Scientists: The Bridge Between Bench and Bedside

Although the number of surgeon-scientists in colorectal surgery is small, a Cleveland Clinic colorectal surgeon-scientist shares his thoughts on what surgeon-scientists bring to the table

Michelle Kang Kim, MD, PhD
August 7, 2023
Helping Women Become Leaders in Gastroenterology

Cleveland Clinic’s Chair of Gastroenterology shares her perspective on what it takes to become a leader in a specialty where women are underrepresented

IBD consultation
March 28, 2023
Advanced Practice Provider IBD Fellowship Enters Year Two

The unique program addresses an unmet need and now looks to expand following its successful first year

DDI 774058 Viars 04-05-23
February 15, 2023
Digestive Disease & Surgery Institute’s New Director of Research Outlines Vision

A three-step plan aimed at strengthening the institute’s infrastructure includes a renewed focus on mentorship

21-HVI-2519112_bariatric-surgery_650x450
October 31, 2022
New Guidelines Broaden Patients’ Eligibility for Metabolic and Bariatric Surgery

Expert panel endorses greater access based on research showing procedures’ safety and efficacy

21-DDI-2102227-CQD-Anesthesia-DDW-1
May 21, 2021
Endoscopic Retrograde Cholangiopancreatography: Should You Intubate?

Multicenter observational study shows no simple answer

19-DDI-5582-CQDLIVE_Twitter_Social-graphic_Final
November 29, 2019
Cleveland Clinic’s Digestive Disease & Surgery Channel Turns 1

Watch live webcasts, procedural videos and more on Consult QD Live

19-DDI-3810-fetalSurgery-HERO-CQD-650×450
June 19, 2019
Myelomeningocele Repairs Launch the Era of Fetal Surgery at Cleveland Clinic

First two cases set the course for a full spectrum of intrauterine therapies

Ad